Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Motor Activity 249Breast Neoplasms 136Neoplasms 108Prostatic Neoplasms 35Fatigue 35Obesity 25Lung Neoplasms 24Colorectal Neoplasms 24Polycystic Ovary Syndrome 17Colonic Neoplasms 16Ovarian Neoplasms 13Precursor Cell Lymphoblastic Leukemia-Lymphoma 12Pancreatic Neoplasms 11Lymphoma 11Lymphedema 11Hematologic Neoplasms 11Carcinoma, Non-Small-Cell Lung 11Weight Loss 10Rectal Neoplasms 10Multiple Myeloma 10Head and Neck Neoplasms 10Leukemia 9Cardiotoxicity 9Insulin Resistance 8Brain Neoplasms 8Stomach Neoplasms 7Peripheral Nervous System Diseases 7Overweight 6Esophageal Neoplasms 6Cognitive Dysfunction 6

Interventions

Sorafenib 222lenvatinib 147Bevacizumab 131Nivolumab 86atezolizumab 80pembrolizumab 74Radiosurgery 71durvalumab 63sintilimab 61Oxaliplatin 60Fluorouracil 56Doxorubicin 47tislelizumab 46apatinib 44Radiofrequency Ablation 44Hepatectomy 43Leucovorin 41camrelizumab 40Radiotherapy 40tremelimumab 37Magnetic Resonance Spectroscopy 36regorafenib 34Capecitabine 30Immune Checkpoint Inhibitors 29Folfox protocol 29Cisplatin 28Gemcitabine 26Cyclophosphamide 26cabozantinib 25Ipilimumab 25

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Carcinoma, Hepatocellular × Exercise × Clear all
NCT00355238 2023-12-01

A Phase II Open Label Study of BMS-582664 in Locally Advanced or Metastatic Hepatocellular Cancer

Bristol-Myers Squibb

Phase 2 Completed
137 enrolled 20 charts
Gastrointestinal

Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡